Authors: Chen, H Liu, J Merrick, BA Waalkes, MP

Citation: H. Chen et al., Genetic events associated with arsenic-induced malignant transformation: Applications of cDNA microarray technology, MOL CARCINO, 30(2), 2001, pp. 79-87

Authors: Chen, H Liu, J Zhao, CQ Diwan, BA Merrick, BA Waalkes, MP

Citation: H. Chen et al., Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation, TOX APPL PH, 175(3), 2001, pp. 260-268

Authors: Merrick, BA Zhou, W Martin, KJ Jeyarajah, S Parker, CE Selkirk, JK Tomer, KB Borchers, CH

Citation: Ba. Merrick et al., Site-specific phosphorylation of human p53 protein determined by mass spectrometry, BIOCHEM, 40(13), 2001, pp. 4053-4066

Authors: Cobbs, CS Samanta, M Harkins, LE Gillespie, GY Merrick, BA MacMillan-Crow, LA

Citation: Cs. Cobbs et al., Evidence for peroxynitrite-mediated modifications to p53 in human gliomas:Possible functional consequences, ARCH BIOCH, 394(2), 2001, pp. 167-172

Authors: Zhou, W Merrick, BA Khaledi, MG Tomer, KB

Citation: W. Zhou et al., Detection and sequencing of phosphopeptides affinity bound to immobilized metal ion beads by matrix-assisted laser desorption/ionization mass spectrometry, J AM SOC M, 11(4), 2000, pp. 273-282

Authors: Zhao, W He, CY Rotter, V Merrick, BA Selkirk, JK

Citation: W. Zhao et al., An intragenic deletion of nuclear localization signal-1 of p53 tumor suppressor gene results in loss of apoptosis in murine fibroblasts, CANCER LETT, 147(1-2), 1999, pp. 101-108